These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 34920370)

  • 1. Co-delivery of dihydroartemisinin and pyropheophorbide-iron elicits ferroptosis to potentiate cancer immunotherapy.
    Han W; Duan X; Ni K; Li Y; Chan C; Lin W
    Biomaterials; 2022 Jan; 280():121315. PubMed ID: 34920370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydroartemisinin elicits immunogenic death through ferroptosis-triggered ER stress and DNA damage for lung cancer immunotherapy.
    Han N; Yang ZY; Xie ZX; Xu HZ; Yu TT; Li QR; Li LG; Peng XC; Yang XX; Hu J; Xu X; Chen X; Wang MF; Li TF
    Phytomedicine; 2023 Apr; 112():154682. PubMed ID: 36739636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fe-MnO
    Huang D; Xu D; Chen W; Wu R; Wen Y; Liu A; Lin L; Lin X; Wang X
    Biomed Pharmacother; 2023 May; 161():114431. PubMed ID: 36827713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Dihydroartemisinin-Loaded Nanoreactor Motivates Anti-Cancer Immunotherapy by Synergy-Induced Ferroptosis to Activate Cgas/STING for Reprogramming of Macrophage.
    Li LG; Yang XX; Xu HZ; Yu TT; Li QR; Hu J; Peng XC; Han N; Xu X; Chen NN; Chen X; Tang JM; Li TF
    Adv Healthc Mater; 2023 Nov; 12(28):e2301561. PubMed ID: 37567571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin.
    Yang XX; Xu X; Wang MF; Xu HZ; Peng XC; Han N; Yu TT; Li LG; Li QR; Chen X; Wen Y; Li TF
    J Nanobiotechnology; 2022 May; 20(1):230. PubMed ID: 35568865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritin.
    Du J; Wang T; Li Y; Zhou Y; Wang X; Yu X; Ren X; An Y; Wu Y; Sun W; Fan W; Zhu Q; Wang Y; Tong X
    Free Radic Biol Med; 2019 Feb; 131():356-369. PubMed ID: 30557609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic Therapy Mediated by Nontoxic Core-Shell Nanoparticles Synergizes with Immune Checkpoint Blockade To Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer.
    Duan X; Chan C; Guo N; Han W; Weichselbaum RR; Lin W
    J Am Chem Soc; 2016 Dec; 138(51):16686-16695. PubMed ID: 27976881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells.
    Chen Y; Mi Y; Zhang X; Ma Q; Song Y; Zhang L; Wang D; Xing J; Hou B; Li H; Jin H; Du W; Zou Z
    J Exp Clin Cancer Res; 2019 Sep; 38(1):402. PubMed ID: 31519193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydroartemisinin triggers ferroptosis in primary liver cancer cells by promoting and unfolded protein response‑induced upregulation of CHAC1 expression.
    Wang Z; Li M; Liu Y; Qiao Z; Bai T; Yang L; Liu B
    Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34558645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable iron-coordinated hollow polydopamine nanospheres for dihydroartemisinin delivery and selectively enhanced therapy in tumor cells.
    Dong L; Wang C; Zhen W; Jia X; An S; Xu Z; Zhang W; Jiang X
    J Mater Chem B; 2019 Oct; 7(40):6172-6180. PubMed ID: 31559402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal Clearable Ultrasmall Single-Crystal Fe Nanoparticles for Highly Selective and Effective Ferroptosis Therapy and Immunotherapy.
    Liang H; Wu X; Zhao G; Feng K; Ni K; Sun X
    J Am Chem Soc; 2021 Sep; 143(38):15812-15823. PubMed ID: 34473493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TUG1/MAZ/FTH1 Axis Attenuates the Antiglioma Effect of Dihydroartemisinin by Inhibiting Ferroptosis.
    Gong H; Gao M; Lin Y; Liu J; Hu Z; Liu J
    Oxid Med Cell Longev; 2022; 2022():7843863. PubMed ID: 36164395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of ferroptosis and pyroptosis dual induction by triptolide nano-MOFs for immunotherapy of Melanoma.
    Wang S; Guo Q; Xu R; Lin P; Deng G; Xia X
    J Nanobiotechnology; 2023 Oct; 21(1):383. PubMed ID: 37858186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox Dyshomeostasis with Dual Stimuli-Activatable Dihydroartemisinin Nanoparticles to Potentiate Ferroptotic Therapy of Pancreatic Cancer.
    Wang Y; Chen F; Zhou H; Huang L; Ye J; Liu X; Sheng W; Gao W; Yu H; Wang F
    Small Methods; 2023 May; 7(5):e2200888. PubMed ID: 36446643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron oxide@chlorophyll clustered nanoparticles eliminate bladder cancer by photodynamic immunotherapy-initiated ferroptosis and immunostimulation.
    Chin YC; Yang LX; Hsu FT; Hsu CW; Chang TW; Chen HY; Chen LY; Chia ZC; Hung CH; Su WC; Chiu YC; Huang CC; Liao MY
    J Nanobiotechnology; 2022 Aug; 20(1):373. PubMed ID: 35953837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEGylated-Paclitaxel and Dihydroartemisinin Nanoparticles for Simultaneously Delivering Paclitaxel and Dihydroartemisinin to Colorectal Cancer.
    Phung CD; Le TG; Nguyen VH; Vu TT; Nguyen HQ; Kim JO; Yong CS; Nguyen CN
    Pharm Res; 2020 Jun; 37(7):129. PubMed ID: 32548664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferroptosis plays an essential role in the antimalarial mechanism of low-dose dihydroartemisinin.
    Li S; Xu W; Wang H; Tang T; Ma J; Cui Z; Shi H; Qin T; Zhou H; Li L; Jiang T; Li C
    Biomed Pharmacother; 2022 Apr; 148():112742. PubMed ID: 35228063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydroartemisinin alleviates hepatic fibrosis through inducing ferroptosis in hepatic stellate cells.
    Zhang Z; Wang X; Wang Z; Zhang Z; Cao Y; Wei Z; Shao J; Chen A; Zhang F; Zheng S
    Biofactors; 2021 Sep; 47(5):801-818. PubMed ID: 34129254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydroartemisinin (DHA) induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cells.
    Lin R; Zhang Z; Chen L; Zhou Y; Zou P; Feng C; Wang L; Liang G
    Cancer Lett; 2016 Oct; 381(1):165-75. PubMed ID: 27477901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Combined Effect of Artemisinin and Ferroptosis Inducer RSL3 against
    Huang M; Cao X; Jiang Y; Shi Y; Ma Y; Hu D; Song X
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613672
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.